Hormonal pleiotropy occurs when a part of the endocrine system (e.g., hormone concentrations) influences the expression of two or more phenotypes. Although hormonal pleiotropy may have similar evolutionary consequences as genetic pleiotropy, most conceptual and empirical work on its putative evolutionary consequences to date has focused on identifying whether the different components of an endocrine axis (titer, receptor expression, etc.) that affect trait expression are themselves able to evolve independently from one another. This is important because if these different components evolve together, the expression of two traits affected by the same hormone may be yoked and evolve non-independently. Here, we first describe methodological approaches used to identify how hormonal pleiotropy could cause the co-evolution of performance and life history traits. We then focus on a similar but less studied concept about how hormonal pleiotropy can affect phenotypic responses to selection. If the expression of two traits is affected by the same hormone, the magnitude of the phenotypic response to selection may be exacerbated or retarded compared to the absence of this hormonal pleiotropy. We use classical concepts from quantitative genetics to discuss an approach for identifying whether hormonal pleiotropy has such evolutionary consequences using data collected from longitudinal studies of wild animals. We develop a simple quantitative genetics model to derive predictions about the conditions under which hormonal pleiotropy would affect the response to selection. We focus on performance and life history traits and how the effects of hormonal pleiotropy on the evolution of these traits depend upon the genetic correlations between the hormone and traits as well as the direction and strength of selection on the two traits. Finally, we review the literature for examples that have estimated these model parameters to characterize the studies that have or have not found support for these model predictions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/icb/icx064 | DOI Listing |
Clin Rheumatol
December 2024
Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, 230032, Anhui, China.
Population-based studies have been inconsistent in terms of the relationship between bone mineral density (BMD) and the progression of osteoarthritis. This study aimed to evaluate the causal relationship between BMD and the risk of joint replacement in patients with osteoarthritis. We performed a two-sample Mendelian randomization (MR) analysis to determine the association of BMD of the total body, femoral neck, and lumbar spine with the risk of hip and knee replacements.
View Article and Find Full Text PDFBrain Behav
December 2024
Department of Neurosurgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Background: Cholesterol-lowering medications, blood pressure medication, insulin, and exogenous hormones (including hormone replacement therapy, oral contraceptives, and minipills) are commonly utilized in clinical practice. Recent studies indicate that the use of these medications may significantly influence the occurrence and progression of cerebral infarction. This study aims to investigate the relationship between these medications and cerebral infarction using Mendelian randomization (MR) analysis, with the goal of offering valuable insights for the clinical management of cerebral infarction.
View Article and Find Full Text PDFGrowth hormone (GH) is a pituitary derived endocrine hormone required for normal post-natal growth and development. Hypo or hypersecretion of endocrine GH results in two pathologic conditions, namely GH deficiency (GHD) and acromegaly. Additionally, GH is also produced in non-pituitary and tumoral tissues where it acts rather as a cellular growth factor with an autocrine/paracrine mode of action.
View Article and Find Full Text PDFFront Oncol
November 2024
The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
Background: Observational investigations have indicated a notable correlation between body mass index (BMI) and breast cancer (BC). Nevertheless, the precise biological pathways driving this correlation remain ambiguous. Consequently, we utilized Mendelian randomization (MR) techniques to explore the causative link between BMI and genetic predisposition to BC, as well as the potential intermediary influences.
View Article and Find Full Text PDFEndometriosis is a common gynecologic condition that causes chronic life-altering symptoms including pain, infertility, and elevated cancer risk. There is an urgent need for new non-hormonal targeted therapeutics to treat endometriosis, but until very recently, the cellular and molecular signatures of endometriotic lesions were undefined, severely hindering the development of clinical advances. Integrating inherited risk data from analyses of >450,000 individuals with ∼350,000 single cell transcriptomes from 21 patients, we uncover M2-macrophages as candidate drivers of disease susceptibility, and nominate IL1 signaling as a central hub impacted by germline genetic variation associated with endometriosis.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!